Evaluation of C-Scan System in Providing Structural Information and Detection of Polypoid Lesions in High Risk Subjects

NACompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

January 28, 2018

Primary Completion Date

January 26, 2020

Study Completion Date

January 26, 2020

Conditions
High Risk (Above Average) SubjectsNon Compliant Patients for Colo Rectal Cancer [CRC] ScreeningCounterindicated Patients for Colonoscopy
Interventions
DEVICE

C-Scan System

"Each subject will ingest the capsule within 30 days prior to colonoscopy. The results of the C-Scan review will be compared to the findings of colonoscopy.~1. To establish the efficacy of C-Scan Capsule System and FIT in detecting patients with polypoid lesions ≥ 10mm, compared with Optical Colonoscopy~2. To evaluate the safety of the C-Scan Capsule System procedure"

Trial Locations (7)

Unknown

Rambam Medical Center, Haifa

Haemek Medical Center, Afula

Soroka Medical Center, Beersheba

Bnai-Zion Medical Center, Haifa

Meir Medical Center, Kfar Saba

Laniado Medical Center, Netanya

Tel Aviv Sorasky Medical Center, Tel Aviv

All Listed Sponsors
lead

Check-Cap Ltd.

INDUSTRY

NCT03356002 - Evaluation of C-Scan System in Providing Structural Information and Detection of Polypoid Lesions in High Risk Subjects | Biotech Hunter | Biotech Hunter